Skip to content
PubMed This is a summary of 105 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 105 referenced papers

Top Authors

Mary Mcdermott
Northwestern University
Michael H. Criqui
University of California San Diego
Michael S. Conte
University of California, San Francisco
Tamar S. Polonsky
University of Chicago
Luigi Ferrucci
National Institute on Aging
Melina R. Kibbe
University of Virginia
Lü Tian
Stanford University
Lihui Zhao
Northwestern University
Eric A. Secemsky
Beth Israel Deaconess Medical Center

Top Institutions

Ranked by publications Top 10 institutions
08

University of Chicago

Chicago, United States

26 papers

References

References (105)
  1. 1

    Epidemiology of peripheral artery disease.

    Criqui MH, Aboyans V

    Circulation research 2015; (116(9)):1509-26 doi:10.1161/CIRCRESAHA.116.303849.

    PMID: 25908725
  2. 2

    Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia.

    McDermott MM

    Circulation research 2015; (116(9)):1540-50 doi:10.1161/CIRCRESAHA.114.303517.

    PMID: 25908727
  3. 3

    Endovascular intervention for peripheral artery disease.

    Thukkani AK, Kinlay S

    Circulation research 2015; (116(9)):1599-613 doi:10.1161/CIRCRESAHA.116.303503.

    PMID: 25908731
  4. 4

    Clinical Interest of Ambulatory Assessment of Physical Activity and Walking Capacity in Peripheral Artery Disease.

    de Müllenheim PY, Chaudru S, Mahé G, et al.

    Scandinavian journal of medicine & science in sports 2016; (26(7)):716-30 doi:10.1111/sms.12512.

    PMID: 26173488
  5. 5

    Discordant Diagnosis of Lower Extremity Peripheral Artery Disease Using American Heart Association Postexercise Guidelines.

    Mahe G, Pollak AW, Liedl DA, et al.

    Medicine 2015; (94(31)):e1277 doi:10.1097/MD.0000000000001277.

    PMID: 26252297
  6. 6

    The management of diabetic foot: A clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine.

    Hingorani A, LaMuraglia GM, Henke P, et al.

    Journal of vascular surgery 2016; (63(2 Suppl)):3S-21S.

    PMID: 26804367
  7. 7

    Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study.

    Arroyo D, Betriu A, Valls J, et al.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2017; (32(3)):513-520 doi:10.1093/ndt/gfw039.

    PMID: 27190385
  8. 8

    Endovascular treatment of lower extremity peripheral arterial disease.

    Klein AJ, Ross CB

    Trends in cardiovascular medicine 2016; (26(6)):495-512.

    PMID: 27345154
  9. 9

    A study of risk factors and foot care behavior among diabetics.

    Nongmaithem M, Bawa AP, Pithwa AK, et al.

    Journal of family medicine and primary care 2016; (5(2)):399-403 doi:10.4103/2249-4863.192340.

    PMID: 27843849
  10. 10

    Depression in patients with peripheral arterial disease: A systematic review.

    Brostow DP, Petrik ML, Starosta AJ, Waldo SW

    European journal of cardiovascular nursing 2017; (16(3)):181-193 doi:10.1177/1474515116687222.

    PMID: 28051339
  11. 11

    Medical management of claudication.

    Ratchford EV

    Journal of vascular surgery 2017; (66(1)):275-280 doi:10.1016/j.jvs.2017.02.040.

    PMID: 28533077
  12. 12

    Validation of the Vascular quality of life questionnaire - 6 for clinical use in patients with lower limb peripheral arterial disease.

    Larsen ASF, Reiersen AT, Jacobsen MB, et al.

    Health and quality of life outcomes 2017; (15(1)):184 doi:10.1186/s12955-017-0760-3.

    PMID: 28938901
  13. 13

    Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.

    Anand SS, Bosch J, Eikelboom JW, et al.

    Lancet (London, England) 2018; (391(10117)):219-229 doi:10.1016/S0140-6736(17)32409-1.

    PMID: 29132880
  14. 14

    Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).

    Bonaca MP, Nault P, Giugliano RP, et al.

    Circulation 2018; (137(4)):338-350 doi:10.1161/CIRCULATIONAHA.117.032235.

    PMID: 29133605
  15. 15

    Antithrombotic treatment in peripheral artery disease.

    Olinic DM, Tataru DA, Homorodean C, et al.

    VASA. Zeitschrift fur Gefasskrankheiten 2018; (47(2)):99-108 doi:10.1024/0301-1526/a000676.

    PMID: 29160765
  16. 16

    [Epidemiology of lower extremity artery disease].

    Aboyans V, Sevestre MA, Désormais I, et al.

    Presse medicale (Paris, France : 1983) 2018; (47(1)):38-46 doi:10.1016/j.lpm.2018.01.012.

    PMID: 29449058
  17. 17

    Exercise Rehabilitation for Peripheral Artery Disease: A REVIEW.

    McDermott MM

    Journal of cardiopulmonary rehabilitation and prevention 2018; (38(2)):63-69 doi:10.1097/HCR.0000000000000343.

    PMID: 29465495
  18. 18

    The association of comorbid depression with mortality and amputation in veterans with peripheral artery disease.

    Arya S, Lee S, Zahner GJ, et al.

    Journal of vascular surgery 2018; (68(2)):536-545.e2 doi:10.1016/j.jvs.2017.10.092.

    PMID: 29588133
  19. 19

    Minimal clinically important differences in treadmill, 6-minute walk, and patient-based outcomes following supervised and home-based exercise in peripheral artery disease.

    Gardner AW, Montgomery PS, Wang M

    Vascular medicine (London, England) 2018; (23(4)):349-357 doi:10.1177/1358863X18762599.

    PMID: 29671381
  20. 20

    Comparison of different exercise ankle pressure indices in the diagnosis of peripheral artery disease.

    Aday AW, Kinlay S, Gerhard-Herman MD

    Vascular medicine (London, England) 2018; (23(6)):541-548 doi:10.1177/1358863X18781723.

    PMID: 29992854
  21. 21

    Pathology of Peripheral Artery Disease in Patients With Critical Limb Ischemia.

    Narula N, Dannenberg AJ, Olin JW, et al.

    Journal of the American College of Cardiology 2018; (72(18)):2152-2163 doi:10.1016/j.jacc.2018.08.002.

    PMID: 30166084
  22. 22

    Oxidative Stress and Arterial Dysfunction in Peripheral Artery Disease.

    Ismaeel A, Brumberg RS, Kirk JS, et al.

    Antioxidants (Basel, Switzerland) 2018; (7(10)) doi:10.3390/antiox7100145.

    PMID: 30347720
  23. 23

    Meta-analysis of clinical trials examining the benefit of structured home exercise in patients with peripheral artery disease.

    Golledge J, Singh TP, Alahakoon C, et al.

    The British journal of surgery 2019; (106(4)):319-331 doi:10.1002/bjs.11101.

    PMID: 30791089
  24. 24

    Lower Extremity Peripheral Artery Disease: Diagnosis and Treatment.

    Firnhaber JM, Powell CS

    American family physician 2019; (99(6)):362-369.

    PMID: 30874413
  25. 25

    A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.

    Almasri J, Adusumalli J, Asi N, et al.

    Journal of vascular surgery 2019; (69(6S)):126S-136S doi:10.1016/j.jvs.2018.01.071.

    PMID: 31159976
  26. 26

    Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia.

    Conte MS, Bradbury AW, Kolh P, et al.

    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2019; (58(1S)):S1-S109.e33 doi:10.1016/j.ejvs.2019.05.006.

    PMID: 31182334
  27. 27

    Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis.

    Song P, Rudan D, Zhu Y, et al.

    The Lancet. Global health 2019; (7(8)):e1020-e1030 doi:10.1016/S2214-109X(19)30255-4.

    PMID: 31303293
  28. 28

    Cardiovascular long-term outcome and prophylactic treatment patterns in peripheral arterial disease in a population-based cohort.

    Sartipy F, Lundin F, Wahlberg E, Sigvant B

    European heart journal. Quality of care & clinical outcomes 2019; (5(4)):310-320 doi:10.1093/ehjqcco/qcz037.

    PMID: 31304962
  29. 29

    Relationship Between Cauda Equina Conduction Time and Type of Neurogenic Intermittent Claudication due to Lumbar Spinal Stenosis.

    Nagao Y, Imajo Y, Funaba M, et al.

    Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society 2020; (37(1)):62-67 doi:10.1097/WNP.0000000000000607.

    PMID: 31335564
  30. 30

    Supervised walking exercise therapy improves gait biomechanics in patients with peripheral artery disease.

    Schieber MN, Pipinos II, Johanning JM, et al.

    Journal of vascular surgery 2020; (71(2)):575-583 doi:10.1016/j.jvs.2019.05.044.

    PMID: 31443974
  31. 31

    Comparing 6-minute walk versus treadmill walking distance as outcomes in randomized trials of peripheral artery disease.

    McDermott MM, Guralnik JM, Tian L, et al.

    Journal of vascular surgery 2020; (71(3)):988-1001 doi:10.1016/j.jvs.2019.05.058.

    PMID: 31870756
  32. 32

    Meaningful change in 6-minute walk in people with peripheral artery disease.

    McDermott MM, Tian L, Criqui MH, et al.

    Journal of vascular surgery 2021; (73(1)):267-276.e1 doi:10.1016/j.jvs.2020.03.052.

    PMID: 32335305
  33. 33

    Association of six-minute walk distance with subsequent lower extremity events in peripheral artery disease.

    Nayak P, Guralnik JM, Polonsky TS, et al.

    Vascular medicine (London, England) 2020; (25(4)):319-327 doi:10.1177/1358863X20901599.

    PMID: 32338582
  34. 34

    Molecular complexities underlying the vascular complications of diabetes mellitus - A comprehensive review.

    Paul S, Ali A, Katare R

    Journal of diabetes and its complications 2020; (34(8)):107613 doi:10.1016/j.jdiacomp.2020.107613.

    PMID: 32505477
  35. 35

    Pathologic Disparities Between Peripheral Artery Disease and Coronary Artery Disease.

    Narula N, Olin JW, Narula N

    Arteriosclerosis, thrombosis, and vascular biology 2020; (40(9)):1982-1989 doi:10.1161/ATVBAHA.119.312864.

    PMID: 32673526
  36. 36

    Efficacy and Safety of Antiplatelet Therapies in Symptomatic Peripheral Artery Disease: A Systematic Review and Network Meta-Analysis.

    De Carlo M, Di Minno G, Sayre T, et al.

    Current vascular pharmacology 2021; (19(5)):542-555 doi:10.2174/1570161118666200820141131.

    PMID: 32819249
  37. 37

    The Role of Lower Extremity Amputation in Chronic Limb-Threatening Ischemia.

    Kim TI, Mena C, Sumpio BE

    The International journal of angiology : official publication of the International College of Angiology, Inc 2020; (29(3)):149-155 doi:10.1055/s-0040-1710075.

    PMID: 32904807
  38. 38

    Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease: A Subanalysis of the COMPASS Randomized Clinical Trial.

    Kaplovitch E, Eikelboom JW, Dyal L, et al.

    JAMA cardiology 2021; (6(1)):21-29 doi:10.1001/jamacardio.2020.4390.

    PMID: 32997098
  39. 39

    The accuracy of toe brachial index and ankle brachial index in the diagnosis of lower limb peripheral arterial disease: A systematic review and meta-analysis.

    Herraiz-Adillo Á, Cavero-Redondo I, Álvarez-Bueno C, et al.

    Atherosclerosis 2020; (315()):81-92 doi:10.1016/j.atherosclerosis.2020.09.026.

    PMID: 33036766
  40. 40

    Validation of the Global Limb Anatomic Staging System in first-time lower extremity revascularization.

    Liang P, Marcaccio CL, Darling JD, et al.

    Journal of vascular surgery 2021; (73(5)):1683-1691.e1 doi:10.1016/j.jvs.2020.08.151.

    PMID: 33091516
  41. 41

    Peripheral Artery Disease in Diabetes Mellitus: Focus on Novel Treatment Options.

    Demarchi A, Somaschini A, Cornara S, Androulakis E

    Current pharmaceutical design 2020; (26(46)):5953-5968 doi:10.2174/1389201021666201126143217.

    PMID: 33243109
  42. 42

    Exercise training for intermittent claudication: a narrative review and summary of guidelines for practitioners.

    Harwood AE, Pymer S, Ingle L, et al.

    BMJ open sport & exercise medicine 2020; (6(1)):e000897 doi:10.1136/bmjsem-2020-000897.

    PMID: 33262892
  43. 43

    Use of the walking impairment questionnaire as a measure of functional assessment.

    Poredos P, Zlajpah U, Poredos P, et al.

    VASA. Zeitschrift fur Gefasskrankheiten 2021; (50(4)):286-293 doi:10.1024/0301-1526/a000941.

    PMID: 33661020
  44. 44

    Evidence-Based Recommendations for Medical Management of Peripheral Artery Disease.

    Golledge J, Drovandi A

    Journal of atherosclerosis and thrombosis 2021; (28(6)):573-583 doi:10.5551/jat.62778.

    PMID: 33746159
  45. 45

    A Propensity-Matched Analysis of Endovascular Intervention versus Open Nonautologous Bypass as Initial Therapy in Patients with Chronic Limb-Threatening Ischemia.

    Futchko J, Friedmann P, Phair J, et al.

    Annals of vascular surgery 2021; (75()):194-204 doi:10.1016/j.avsg.2021.02.024.

    PMID: 33819581
  46. 46

    Lower Extremity Peripheral Artery Disease Without Chronic Limb-Threatening Ischemia: A Review.

    Polonsky TS, McDermott MM

    JAMA 2021; (325(21)):2188-2198 doi:10.1001/jama.2021.2126.

    PMID: 34061140
  47. 47

    Perceived Versus Objective Change in Walking Ability in Peripheral Artery Disease: Results from 3 Randomized Clinical Trials of Exercise Therapy.

    McDermott MM, Tian L, Criqui MH, et al.

    Journal of the American Heart Association 2021; (10(12)):e017609 doi:10.1161/JAHA.120.017609.

    PMID: 34075780
  48. 48

    Diabetes Mellitus and Lower Extremity Peripheral Artery Disease.

    Takahara M

    JMA journal 2021; (4(3)):225-231 doi:10.31662/jmaj.2021-0042.

    PMID: 34414316
  49. 49

    Smoking and the Pathophysiology of Peripheral Artery Disease.

    Wang W, Zhao T, Geng K, et al.

    Frontiers in cardiovascular medicine 2021; (8()):704106 doi:10.3389/fcvm.2021.704106.

    PMID: 34513948
  50. 50

    Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease.

    Belch JJF, Brodmann M, Baumgartner I, et al.

    VASA. Zeitschrift fur Gefasskrankheiten 2021; (50(6)):401-411 doi:10.1024/0301-1526/a000969.

    PMID: 34743585
  51. 51

    Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease: European Atherosclerosis Society/European Society of Vascular Medicine Joint Statement.

    Belch JJF, Brodmann M, Baumgartner I, et al.

    Atherosclerosis 2021; (338()):55-63 doi:10.1016/j.atherosclerosis.2021.09.022.

    PMID: 34763902
  52. 52

    Comprehensive cardiac rehabilitation program for peripheral arterial diseases.

    Yasu T

    Journal of cardiology 2022; (80(4)):303-305 doi:10.1016/j.jjcc.2021.11.011.

    PMID: 34857431
  53. 53

    Inadequacies of Physical Examination in Patients with Acute Lower Limb Ischemia Are Associated with Dreadful Consequences.

    Kulezic A, Macek M, Acosta S

    Annals of vascular surgery 2022; (82()):190-196 doi:10.1016/j.avsg.2021.10.067.

    PMID: 34902465
  54. 54

    Contemporary Medical Therapies for Patients with Peripheral Artery Disease and Concomitant Type 2 Diabetes Mellitus: a Review of Current Evidence.

    Narcisse DI, Katzenberger DR, Gutierrez JA

    Current cardiology reports 2022; (24(5)):567-576 doi:10.1007/s11886-022-01677-6.

    PMID: 35201560
  55. 55

    Differences in Symptom Presentation in Women and Men with Confirmed Lower Limb Peripheral Artery Disease: A Systematic Review and Meta-Analysis.

    Porras CP, Bots ML, Teraa M, et al.

    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2022; (63(4)):602-612 doi:10.1016/j.ejvs.2021.12.039.

    PMID: 35248439
  56. 56

    The Role of Endovascular Procedure for Peripheral Arterial Disease in Diabetic Patients With Chronic Limb-Threatening Ischemia.

    Santosa Y, Harca AD, Sukmaja E, Yuwono A

    Cureus 2022; (14(4)):e23857 doi:10.7759/cureus.23857.

    PMID: 35530835
  57. 57

    [Conservative treatment of peripheral arterial disease].

    Espinola-Klein C, Weißer G

    Innere Medizin (Heidelberg, Germany) 2022; (63(6)):579-583 doi:10.1007/s00108-022-01342-8.

    PMID: 35532800
  58. 58

    Decision Aids for Determining Facility Versus Non-Facility-Based Exercise in Those with Symptomatic Peripheral Artery Disease.

    Ehrman JK, Salisbury D, Treat-Jacobson D

    Current cardiology reports 2022; (24(8)):1031-1039 doi:10.1007/s11886-022-01720-6.

    PMID: 35587854
  59. 59

    Optimal conduit choice for open lower extremity bypass in chronic limb-threatening ischemia.

    Thomas JP, So KL, Turner JT, et al.

    Seminars in vascular surgery 2022; (35(2)):172-179 doi:10.1053/j.semvascsurg.2022.05.001.

    PMID: 35672107
  60. 60

    Peripheral arterial disease and hypertension.

    Gupta A, Patel RAG

    Current opinion in cardiology 2022; (37(5)):403-412 doi:10.1097/HCO.0000000000000983.

    PMID: 35880444
  61. 61

    State-of-the-Art Endovascular Therapies for the Femoropopliteal Segment: Are We There Yet?

    Mosarla RC, Armstrong E, Bitton-Faiwiszewski Y, et al.

    Journal of the Society for Cardiovascular Angiography & Interventions 2022; (1(5)) doi:10.1016/j.jscai.2022.100439.

    PMID: 36268042
  62. 62

    Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia.

    Farber A, Menard MT, Conte MS, et al.

    The New England journal of medicine 2022; (387(25)):2305-2316 doi:10.1056/NEJMoa2207899.

    PMID: 36342173
  63. 63

    Influencing factors for the recurrence of diabetic foot ulcers: A meta-analysis.

    Guo Q, Ying G, Jing O, et al.

    International wound journal 2023; (20(5)):1762-1775 doi:10.1111/iwj.14017.

    PMID: 36385501
  64. 64

    The Role of the Coagulation System in Peripheral Arterial Disease: Interactions with the Arterial Wall and Its Vascular Microenvironment and Implications for Rational Therapies.

    Miceli G, Basso MG, Rizzo G, et al.

    International journal of molecular sciences 2022; (23(23)) doi:10.3390/ijms232314914.

    PMID: 36499242
  65. 65

    Etiology, Epidemiology, and Disparities in the Burden of Diabetic Foot Ulcers.

    McDermott K, Fang M, Boulton AJM, et al.

    Diabetes care 2023; (46(1)):209-221 doi:10.2337/dci22-0043.

    PMID: 36548709
  66. 66

    Mesenchymal stem cell-based therapy for non-healing wounds due to chronic limb-threatening ischemia: A review of preclinical and clinical studies.

    Huerta CT, Voza FA, Ortiz YY, et al.

    Frontiers in cardiovascular medicine 2023; (10()):1113982 doi:10.3389/fcvm.2023.1113982.

    PMID: 36818343
  67. 67

    Regulation of endothelial function by cigarette smoke and next-generation tobacco and nicotine products.

    Klein J, Diaba-Nuhoho P, Giebe S, et al.

    Pflugers Archiv : European journal of physiology 2023; (475(7)):835-844 doi:10.1007/s00424-023-02824-w.

    PMID: 37285061
  68. 68

    Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2023 update).

    Bus SA, Sacco ICN, Monteiro-Soares M, et al.

    Diabetes/metabolism research and reviews 2024; (40(3)):e3651 doi:10.1002/dmrr.3651.

    PMID: 37302121
  69. 69

    Home-Based Exercise Therapy in the Management of Intermittent Claudication: A Systematic Review and Meta-Analysis.

    Twomey A, Khan Z

    Cureus 2023; (15(5)):e39206 doi:10.7759/cureus.39206.

    PMID: 37384085
  70. 70

    Diabetic Foot Ulcers: A Review.

    Armstrong DG, Tan TW, Boulton AJM, Bus SA

    JAMA 2023; (330(1)):62-75 doi:10.1001/jama.2023.10578.

    PMID: 37395769
  71. 71

    Effectiveness of bedside investigations to diagnose peripheral artery disease among people with diabetes mellitus: A systematic review.

    Chuter V, Schaper N, Mills J, et al.

    Diabetes/metabolism research and reviews 2024; (40(3)):e3683 doi:10.1002/dmrr.3683.

    PMID: 37477087
  72. 72

    The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes and a foot ulcer.

    Fitridge R, Chuter V, Mills J, et al.

    Diabetes/metabolism research and reviews 2024; (40(3)):e3686 doi:10.1002/dmrr.3686.

    PMID: 37726988
  73. 73

    Home-Based Walking Exercise and Supervised Treadmill Exercise in Patients With Peripheral Artery Disease: An Individual Participant Data Meta-Analysis.

    Thangada ND, Zhang D, Tian L, et al.

    JAMA network open 2023; (6(9)):e2334590 doi:10.1001/jamanetworkopen.2023.34590.

    PMID: 37733346
  74. 74

    Global burden of peripheral artery disease and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.

    The Lancet. Global health 2023; (11(10)):e1553-e1565 doi:10.1016/S2214-109X(23)00355-8.

    PMID: 37734799
  75. 75

    Association Between Mental Health Burden, Clinical Presentation, and Outcomes in Individuals With Symptomatic Peripheral Artery Disease: A Scientific Statement From the American Heart Association.

    Smolderen KG, Samaan Z, Decker C, et al.

    Circulation 2023; (148(19)):1511-1528 doi:10.1161/CIR.0000000000001178.

    PMID: 37781785
  76. 76

    Lower extremity arterial disease perspective: IUA consensus document on "lead management". Part 1.

    Antignani PL, Gargiulo M, Gastaldi G, et al.

    International angiology : a journal of the International Union of Angiology 2023; (42(5)):382-395 doi:10.23736/S0392-9590.23.05110-6.

    PMID: 37822195
  77. 77

    High risk and low prevalence diseases: Acute limb ischemia.

    Arnold J, Koyfman A, Long B

    The American journal of emergency medicine 2023; (74()):152-158 doi:10.1016/j.ajem.2023.09.052.

    PMID: 37844359
  78. 78

    Hypertension Management in Peripheral Artery Disease: A Mini Review.

    Kharawala A, Nagraj S, Pargaonkar S, et al.

    Current hypertension reviews 2024; (20(1)):1-9 doi:10.2174/0115734021267004231122061712.

    PMID: 38083897
  79. 79

    Dyslipidemia and peripheral arterial disease.

    Yadav A, Sawant V, Singh Bedi V, Yadav K

    Indian heart journal 2024; (76 Suppl 1()):S86-S89 doi:10.1016/j.ihj.2024.01.010.

    PMID: 38224837
  80. 80

    Accuracy of maximal acceleration time of pedal arteries to diagnose critical limb-threatening ischemia.

    Trihan JE, Croquette M, Hersant J, et al.

    Vascular medicine (London, England) 2024; (29(2)):153-162 doi:10.1177/1358863X231226216.

    PMID: 38469710
  81. 81

    Infra-inguinal bypass surgery vs endovascular revascularization for chronic limb-threatening ischemia in average- and high-risk patients.

    Morisaki K, Matsuda D, Guntani A, et al.

    Journal of vascular surgery 2024; (80(1)):204-212.e3 doi:10.1016/j.jvs.2024.03.025.

    PMID: 38522583
  82. 82

    Exercise Therapy for Peripheral Artery Disease.

    Thangada ND, McDermott MM

    Current cardiology reports 2024; (26(5)):405-412 doi:10.1007/s11886-024-02043-4.

    PMID: 38722492
  83. 83

    2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

    Gornik HL, Aronow HD, Goodney PP, et al.

    Circulation 2024; (149(24)):e1313-e1410 doi:10.1161/CIR.0000000000001251.

    PMID: 38743805
  84. 84

    2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

    , Gornik HL, Aronow HD, et al.

    Journal of the American College of Cardiology 2024; (83(24)):2497-2604 doi:10.1016/j.jacc.2024.02.013.

    PMID: 38752899
  85. 85

    Surgery or endovascular therapy for patients with chronic limb-threatening ischemia requiring infrapopliteal interventions.

    Giles KA, Farber A, Menard MT, et al.

    Journal of vascular surgery 2024; (80(5)):1515-1524 doi:10.1016/j.jvs.2024.05.049.

    PMID: 38908805
  86. 86

    [Lower extremity arterial disease (LEAD)].

    Espinola-Klein C

    Herz 2024; (49(4)):313-318 doi:10.1007/s00059-024-05252-3.

    PMID: 38916707
  87. 87

    Challenges and opportunities in the management of type 2 diabetes in patients with lower extremity peripheral artery disease: a tailored diagnosis and treatment review.

    Mahé G, Aboyans V, Cosson E, et al.

    Cardiovascular diabetology 2024; (23(1)):220 doi:10.1186/s12933-024-02325-9.

    PMID: 38926722
  88. 88

    An evaluation of inflammatory and endothelial dysfunction markers as determinants of peripheral arterial disease in those with diabetes mellitus.

    Zaib S, Ahmad S, Khan I, et al.

    Scientific reports 2024; (14(1)):15348 doi:10.1038/s41598-024-65188-w.

    PMID: 38961103
  89. 89

    Comparing the efficacy and safety of endovascular therapy versus surgical revascularization for critical limb-threatening ischemia: A systematic review and Meta-analysis.

    Abouzid MR, Vyas A, Kamel I, et al.

    Progress in cardiovascular diseases 2025; (88()):126-135 doi:10.1016/j.pcad.2024.06.008.

    PMID: 38981532
  90. 90

    Association of Depression with Walking in People with Peripheral Artery Disease: A Post-Hoc Analysis of the BIP Trial.

    Golledge J, Venn A, Leicht A, et al.

    Journal of atherosclerosis and thrombosis 2025; (32(9)):1101-1108 doi:10.5551/jat.65531.

    PMID: 40044157
  91. 91

    Acute Limb Ischemia Interventions.

    Ahmed A, Naeem N, Jain A, et al.

    Interventional cardiology clinics 2025; (14(2)):273-282 doi:10.1016/j.iccl.2024.11.012.

    PMID: 40049853
  92. 92

    Cutting-edge European guidelines for managing lower extremity peripheral arterial disease - Featuring selected insights on PAD management.

    Buso G, Hersant J, Keller S, et al.

    VASA. Zeitschrift fur Gefasskrankheiten 2025; (54(4)):225-234 doi:10.1024/0301-1526/a001186.

    PMID: 40084845
  93. 93

    Systematic review of tracking-based technology for patients with claudication.

    Sivagangan P, Mancuso E, Sanders I, et al.

    Vascular medicine (London, England) 2025; (30(3)):353-363 doi:10.1177/1358863X251316198.

    PMID: 40167373
  94. 94

    Reproducibility and concordance of Pedal Acceleration Time between students, residents and experts operators: Single-center prospective study.

    Marchand H, Lecompte C, Roisin S, et al.

    Vascular diseases (Paris, France) 2025; (50(2)):80-83 doi:10.1016/j.vasdi.2025.02.002.

    PMID: 40757621
  95. 95

    Duration of Supervised Exercise Necessary for Meaningful Improvement in Peripheral Artery Disease.

    McDermott MM, Zhang D, Zhao L, et al.

    Journal of the American Heart Association 2025; (14(18)):e040058 doi:10.1161/JAHA.124.040058.

    PMID: 40913279
  96. 96

    Management of claudication in older adults and the role of exercise therapy.

    Aalami OO, Corriere MA

    Seminars in vascular surgery 2025; (38(3)):271-280 doi:10.1053/j.semvascsurg.2025.07.005.

    PMID: 40921554
  97. 97

    Peripheral artery disease.

    Aboyans V, Canonico ME, Chastaingt L, et al.

    Nature reviews. Disease primers 2025; (11(1)):68 doi:10.1038/s41572-025-00651-0.

    PMID: 40968271
  98. 98

    Trends and Potential Risk Factors of Lower Extremity Peripheral Arterial Disease: Results from the Global Burden of Disease Study 2021.

    Zhang B, Zhang H, Gong H, Ge J

    Pulse (Basel, Switzerland) 2025; (13(1)):140-156 doi:10.1159/000547795.

    PMID: 41246568
  99. 99

    Management of Peripheral Artery Disease in Adults With Diabetes: 2025 ACC Scientific Statement: A Report of the American College of Cardiology.

    Das SR, Bonaca MP, Creager MA, et al.

    Journal of the American College of Cardiology 2025; doi:10.1016/j.jacc.2025.11.027.

    PMID: 41405527
  100. 100

    A narrative review of imaging misallocation in peripheral artery disease: a value-based medicine perspective.

    Raskin D, Partovi S, Levitin A, et al.

    Cardiovascular diagnosis and therapy 2025; (15(6)):1194-1205 doi:10.21037/cdt-2025-426.

    PMID: 41509627
  101. 101

    Durability of Exercise vs. Revascularization in Intermittent Claudication: An Updated Meta-Analysis of Randomized Trials Focusing on Patient-Centered Outcomes.

    Puljevic M, Grubic-Rotkvic P, Dubravcic-Dosen M, et al.

    Healthcare (Basel, Switzerland) 2026; (14(2)) doi:10.3390/healthcare14020170.

    PMID: 41595306
  102. 102

    Current and emerging approaches to managing peripheral artery disease: a specialist review.

    Mohammadi A, Hussein L, Yahyavi A, Shishehbor MH

    Heart (British Cardiac Society) 2026; doi:10.1136/heartjnl-2025-326532.

    PMID: 41965269
  103. 103

    Secondary prevention strategies for patients with lower extremity peripheral artery disease after successful peripheral vascular intervention.

    Gouda P, Secemsky EA, Hess CN, et al.

    American heart journal 2026; (299()):107446 doi:10.1016/j.ahj.2026.107446.

    PMID: 42069036
  104. 104

    Optimal Antithrombotic Therapy for Peripheral Artery Disease: A Systematic Review and Network Meta-Analysis.

    Hiruma Y, Watanabe A, Aikawa T, et al.

    Journal of the American Heart Association 2026; (15(12)):e047301 doi:10.1161/JAHA.125.047301.

    PMID: 42294768
  105. 105

    Smoking Behavior and Major Cardiovascular and Limb Events in Patients With Peripheral Artery Disease.

    Kim HK, Kim MS, Ahn S, et al.

    JAMA network open 2026; (9(8)):e2629337 doi:10.1001/jamanetworkopen.2026.29337.

    PMID: 42616502